Menu
Recruiting NCT04883502

Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs

Observational Bone Loss

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Blood sample collection, Other biological sample collection, Surgical waste collection, Radiological examination and functional exploration.
Who it may be relevant to
Registry conditions: Bone Loss. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Masquelet's induced membrane technique is a two-stage reconstructive surgery for severe bone fractures commonly used by military orthopedists. The particularity of this technique relies on the synthesis of a biological membrane induced by the transient implantation of a surgical cement (= 1st stage surgery). The presence of the induced membrane in the reconstruction space defines a microenvironment or "biological chamber" favourable to osteogenesis, positively influencing the repair of the lesion after implantation of an autologous bone graft (= 2nd stage of surgery). In view of the excellent clinical results obtained with this procedure, the Masquelet technique has gradually become a reference treatment in the field of orthopedic and trauma surgery. However, orthopedic surgeons sometimes observe failures in bone consolidation. To our knowledge, the role played by induced membrane in these therapeutic failures has never been studied.

Interventions

  • Biological Blood sample collection
    A blood sample will be collected at enrollment.
  • Biological Other biological sample collection
    The following biological samples will be collected during the first surgery: * 1 blood sample * 3 fragments of induced membrane * 1 fragment of periosteum
  • Diagnostic test Surgical waste collection
    The pieces of polymethylmethacrylate surgical cement will be collected during the second surgery.
  • Diagnostic test Radiological examination and functional exploration
    A radiological examination and a functional exploration will be performed 6 weeks, 3 months and 6 months after the first surgery

Primary outcome measures

  • Histological profile of induced membrane fragments [Time frame: Through study completion, an average of 6,5 years]
  • Cellular profile of induced membrane fragments [Time frame: Through study completion, an average of 6,5 years]
  • Secretory profile of induced membrane fragments [Time frame: Through study completion, an average of 6,5 years]
  • Gene expression profile of induced membrane fragments [Time frame: Through study completion, an average of 6,5 years]

Eligibility criteria

Inclusion criteria

  • Age ≥ 18 years
  • Patient with traumatic bone loss
  • Patient eligible for the induced membrane technique

Exclusion criteria

  • Patients with post-tumor bone loss
  • Patients who are immunocompromised or under immunosuppressive treatment
  • Patients with chronic inflammatory disease (diabetes, inflammatory bowel disease)
  • Patients with collagenosis
  • Patient with a contraindication to sampling
  • Pregnant or breastfeeding women

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 2 centers
  • Hôpital d'Instruction des Armées Percy — Clamart
  • Hôpital d'Instruction des Armées Bégin — Saint-Mandé

Identifiers

NCT: NCT04883502 · 2019PPRC03 · 2021-A00561-40

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗